GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Notes Receivable

Atomo Diagnostics (ASX:AT1) Notes Receivable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Notes Receivable?

Atomo Diagnostics's Notes Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Atomo Diagnostics Notes Receivable Historical Data

The historical data trend for Atomo Diagnostics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Notes Receivable Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Notes Receivable
- - - - -

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Atomo Diagnostics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Atomo Diagnostics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Atomo Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines